Information about Attana's presentation at Erik Penser Bank's Bolagsdag on June 3 at 16.20
On Thursday, June 3 at 16.20 Attana will participate in Erik Penser Bank’s Bolagsdag where Attana’s CEO, Teodor Aastrup, will present the company and answer questions.
The primary reason for the presentation is to update on the recent progress that has been made within Attana’s new business area, diagnostics. This includes news about a collaboration between Attana, Region Kalmar and the Linnaeus University, Attana's regulatory strategy and the plans going forward.
Preliminary outline for the presentation:
- Attana in short
- Attana Life Science
- Background
- Attana’s solution
- Attana’s track record
- The QCM technology
- Attana Diagnostics
- Background
- Recent progress
- Next steps
The event is live streamed and can be seen on Erik Penser Bank’s Youtube channel.
When: June 3 at 16.20
Where: Digital event accessed through this link
For more information, please contact:
Teodor Aastrup, CEO
teodor.aastrup@attana.com
+46 (0)8 674 57 00
The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated.
About Attana
Attana was founded in 2002 with the vision of in vitro characterization of molecular interactions mimicking in vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit www.attana.com or contact sales@attana.com
Tags:
